Spisulosine (ES-285) induces prostate tumor PC-3 and LNCaP cell death by de novo synthesis of ceramide and PKCζ activation

Ana M. Sánchez, Sophie Malagarie-Cazenave, Nuria Olea, Diana Vara, Carmen Cuevas, Inés Díaz-Laviada

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

During the past decades, intense attention has been focused on the anti-tumor properties of marine compounds which some of them have been revealed as potent apoptotic inducers. In the present work, we studied the mechanism of action of a new compound, Spisulosine (ES-285), isolated from the sea mollusc Spisula polynyma, in the prostate tumor PC-3 and LNCaP cell lines. Spisulosine inhibited cell proliferation with an IC 50 of 1 μM in both cell lines, although it was more effective in the androgen-independent PC-3 cells. The anti-proliferative effect induced by Spisulosine in prostate cells was independent of peroxisome proliferator activated receptor gamma (PPARγ) and phosphatidylinositol 3-kinase/(PI3K/Akt), Jun N-terminal kinase (JNK), p38 or classical protein kinase C (PKCs) pathways, as it was inferred from the results obtained with specific inhibitors of these routes. However, Spisulosine treatment of prostate cells induced an increase in the intracellular ceramide levels, that was totally blocked by the ceramide synthase inhibitor Fumonisin B1, indicating that the ceramide accumulation came from the de novo biosynthesis. Spisulosine also induced in both PC-3 and LNCaP cells, an activation of the atypical PKC isoform, PKCζ, which is one of the target proteins of ceramide. These results indicate that the marine compound Spisulosine inhibits the growth of the prostate PC-3 and LNCaP cells through intracellular ceramide accumulation and PKCζ activation.

Original languageEnglish
Pages (from-to)237-245
Number of pages9
JournalEuropean Journal of Pharmacology
Volume584
Issue number2-3
DOIs
Publication statusPublished - Apr 28 2008

Fingerprint

Protein Kinase C
Prostate
Cell Death
Ceramides
Neoplasms
Spisula
Phosphatidylinositol 3-Kinase
Cell Line
Mollusca
PPAR gamma
spisulosine
ceramide kinase
Phosphatidylinositol 3-Kinases
Oceans and Seas
Androgens
Protein Isoforms
Phosphotransferases
Cell Proliferation
Growth
Proteins

Keywords

  • Cancer
  • Ceramide
  • PKCζ
  • Prostate
  • Spisulosine

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Pharmacology

Cite this

Spisulosine (ES-285) induces prostate tumor PC-3 and LNCaP cell death by de novo synthesis of ceramide and PKCζ activation. / Sánchez, Ana M.; Malagarie-Cazenave, Sophie; Olea, Nuria; Vara, Diana; Cuevas, Carmen; Díaz-Laviada, Inés.

In: European Journal of Pharmacology, Vol. 584, No. 2-3, 28.04.2008, p. 237-245.

Research output: Contribution to journalArticle

Sánchez, Ana M. ; Malagarie-Cazenave, Sophie ; Olea, Nuria ; Vara, Diana ; Cuevas, Carmen ; Díaz-Laviada, Inés. / Spisulosine (ES-285) induces prostate tumor PC-3 and LNCaP cell death by de novo synthesis of ceramide and PKCζ activation. In: European Journal of Pharmacology. 2008 ; Vol. 584, No. 2-3. pp. 237-245.
@article{fe89b728f57b449f96d0ed010c0a6f21,
title = "Spisulosine (ES-285) induces prostate tumor PC-3 and LNCaP cell death by de novo synthesis of ceramide and PKCζ activation",
abstract = "During the past decades, intense attention has been focused on the anti-tumor properties of marine compounds which some of them have been revealed as potent apoptotic inducers. In the present work, we studied the mechanism of action of a new compound, Spisulosine (ES-285), isolated from the sea mollusc Spisula polynyma, in the prostate tumor PC-3 and LNCaP cell lines. Spisulosine inhibited cell proliferation with an IC 50 of 1 μM in both cell lines, although it was more effective in the androgen-independent PC-3 cells. The anti-proliferative effect induced by Spisulosine in prostate cells was independent of peroxisome proliferator activated receptor gamma (PPARγ) and phosphatidylinositol 3-kinase/(PI3K/Akt), Jun N-terminal kinase (JNK), p38 or classical protein kinase C (PKCs) pathways, as it was inferred from the results obtained with specific inhibitors of these routes. However, Spisulosine treatment of prostate cells induced an increase in the intracellular ceramide levels, that was totally blocked by the ceramide synthase inhibitor Fumonisin B1, indicating that the ceramide accumulation came from the de novo biosynthesis. Spisulosine also induced in both PC-3 and LNCaP cells, an activation of the atypical PKC isoform, PKCζ, which is one of the target proteins of ceramide. These results indicate that the marine compound Spisulosine inhibits the growth of the prostate PC-3 and LNCaP cells through intracellular ceramide accumulation and PKCζ activation.",
keywords = "Cancer, Ceramide, PKCζ, Prostate, Spisulosine",
author = "S{\'a}nchez, {Ana M.} and Sophie Malagarie-Cazenave and Nuria Olea and Diana Vara and Carmen Cuevas and In{\'e}s D{\'i}az-Laviada",
year = "2008",
month = "4",
day = "28",
doi = "10.1016/j.ejphar.2008.02.011",
language = "English",
volume = "584",
pages = "237--245",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "2-3",

}

TY - JOUR

T1 - Spisulosine (ES-285) induces prostate tumor PC-3 and LNCaP cell death by de novo synthesis of ceramide and PKCζ activation

AU - Sánchez, Ana M.

AU - Malagarie-Cazenave, Sophie

AU - Olea, Nuria

AU - Vara, Diana

AU - Cuevas, Carmen

AU - Díaz-Laviada, Inés

PY - 2008/4/28

Y1 - 2008/4/28

N2 - During the past decades, intense attention has been focused on the anti-tumor properties of marine compounds which some of them have been revealed as potent apoptotic inducers. In the present work, we studied the mechanism of action of a new compound, Spisulosine (ES-285), isolated from the sea mollusc Spisula polynyma, in the prostate tumor PC-3 and LNCaP cell lines. Spisulosine inhibited cell proliferation with an IC 50 of 1 μM in both cell lines, although it was more effective in the androgen-independent PC-3 cells. The anti-proliferative effect induced by Spisulosine in prostate cells was independent of peroxisome proliferator activated receptor gamma (PPARγ) and phosphatidylinositol 3-kinase/(PI3K/Akt), Jun N-terminal kinase (JNK), p38 or classical protein kinase C (PKCs) pathways, as it was inferred from the results obtained with specific inhibitors of these routes. However, Spisulosine treatment of prostate cells induced an increase in the intracellular ceramide levels, that was totally blocked by the ceramide synthase inhibitor Fumonisin B1, indicating that the ceramide accumulation came from the de novo biosynthesis. Spisulosine also induced in both PC-3 and LNCaP cells, an activation of the atypical PKC isoform, PKCζ, which is one of the target proteins of ceramide. These results indicate that the marine compound Spisulosine inhibits the growth of the prostate PC-3 and LNCaP cells through intracellular ceramide accumulation and PKCζ activation.

AB - During the past decades, intense attention has been focused on the anti-tumor properties of marine compounds which some of them have been revealed as potent apoptotic inducers. In the present work, we studied the mechanism of action of a new compound, Spisulosine (ES-285), isolated from the sea mollusc Spisula polynyma, in the prostate tumor PC-3 and LNCaP cell lines. Spisulosine inhibited cell proliferation with an IC 50 of 1 μM in both cell lines, although it was more effective in the androgen-independent PC-3 cells. The anti-proliferative effect induced by Spisulosine in prostate cells was independent of peroxisome proliferator activated receptor gamma (PPARγ) and phosphatidylinositol 3-kinase/(PI3K/Akt), Jun N-terminal kinase (JNK), p38 or classical protein kinase C (PKCs) pathways, as it was inferred from the results obtained with specific inhibitors of these routes. However, Spisulosine treatment of prostate cells induced an increase in the intracellular ceramide levels, that was totally blocked by the ceramide synthase inhibitor Fumonisin B1, indicating that the ceramide accumulation came from the de novo biosynthesis. Spisulosine also induced in both PC-3 and LNCaP cells, an activation of the atypical PKC isoform, PKCζ, which is one of the target proteins of ceramide. These results indicate that the marine compound Spisulosine inhibits the growth of the prostate PC-3 and LNCaP cells through intracellular ceramide accumulation and PKCζ activation.

KW - Cancer

KW - Ceramide

KW - PKCζ

KW - Prostate

KW - Spisulosine

UR - http://www.scopus.com/inward/record.url?scp=41249098642&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=41249098642&partnerID=8YFLogxK

U2 - 10.1016/j.ejphar.2008.02.011

DO - 10.1016/j.ejphar.2008.02.011

M3 - Article

C2 - 18343365

AN - SCOPUS:41249098642

VL - 584

SP - 237

EP - 245

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 2-3

ER -